IP Library Patent Application 12346736
Patent Application
App. No. 12/346,736

METHODS FOR TREATMENT OF INTESTINAL CARCINOGENESIS WITH RICE BRAN

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/346,736
Abstract

The present invention provides a method for treating colorectal cancer and reducing adenoma development in mammals by administering rice bran.

Claims (23)

1 . A method for treating, reducing or preventing reoccurrence of adenoma development in a mammal, said method comprising:

administering rice bran to said mammal, thereby treating adenoma development.

2 . The method of claim 1 , wherein said mammal is a human being.

3 . The method of claim 2 , wherein the effective dose of rice bran is about 150 g to about 250 g pd per diem, per 70 kg body weight.

4 . The method of claim 1 , wherein said rice bran is stabilized rice bran.

5 . The method of claim 1 , wherein adenoma development is retarded or reduced.

6 . The method of claim 1 , wherein said rice bran exerts a physical effect, hastening fecal transit in said mammal.

7 . The method of claim 1 , wherein said rice bran changes the gastrointestinal microflora and luminal environment to alter the bacterial species population of said mammal.

8 . The method of claim 1 , wherein said rice bran undergo fermentation in the luminal environment, generating short chain fatty acids such as butyrate, which exert an anticarcinogenic effect.

9 . The method of claim 1 , wherein said adenoma is an adenocarcinoma.

10 . The method of claim 1 , wherein said adenoma size and/or distribution development is retarded.

11 . A method for treating or reducing the incidence of colorectal cancer in a mammal, said method comprising:

administering rice bran to said mammal, thereby treating colorectal cancer.

12 . The method of claim 11 , wherein said mammal is a human being.

13 . The method of claim 12 , wherein the effective dose of rice bran is about 150 g to about 250 g per diem, per 70 kg body weight.

14 . The method of claim 11 , wherein said rice bran is stabilized rice bran.

15 . The method of claim 11 , wherein adenocarcinoma development is retarded or reduced.

16 . The method of claim 11 , wherein said rice bran exerts a physical effect, hastening fecal transit in said mammal.

17 . The method of claim 11 , wherein said rice bran changes the gastrointestinal microflora and luminal environment to alter the bacterial species population of said mammal.

18 . The method of claim 11 , wherein said rice bran undergo fermentation in the luminal environment, generating short chain fatty acids such as butyrate, which exert an anticarcinogenic effect.

19 . The method of claim 11 , wherein said adenoma size and/or distribution development is retarded.

20 . A method of chemopreventive intervention in a human with existing intestinal polyps, said method comprising:

administrating rice bran at a dose of about 150 g to about 250 g per diem, per 70 kg body weight, thereby preventing or reducing cancer in said human with existing intestinal polyps.

Assignments (2)
SECURITY AGREEMENT Recorded Jan 23, 2012
From: NUTRACEA
To: VISLOCKY, GREGORY J.; HALPERN, BARUCH
Reel/Frame 027579/0801 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2009
From: GESCHER, ANDREAS J.; VERSCHOYLE, RICHARD D.
To: NUTRACEA
Reel/Frame 022450/0897 →